Bacterial vaginosis is not contagious in the way most people understand the word, but the bacteria involved can and do pass between sexual partners. For decades, researchers have debated whether BV fits the definition of a sexually transmitted infection. The evidence has shifted substantially in recent years, and the honest answer is more complicated than a simple yes or no. What’s clear is that sexual activity plays a significant role in who gets BV, how it recurs, and potentially how it spreads, even though non-sexual factors also matter.
Why the “Is It Contagious?” Question Is So Hard to Answer
BV isn’t caused by a single pathogen the way chlamydia or gonorrhea is. Instead, it’s a shift in the entire vaginal ecosystem. A healthy vaginal microbiome is dominated by Lactobacillus bacteria, which produce lactic acid and other antimicrobial compounds that keep the environment acidic and hostile to harmful microbes.1PubMed Central. The Female Vaginal Microbiome in Health and Bacterial Vaginosis BV happens when those protective Lactobacillus populations crash and are replaced by a diverse mix of anaerobic bacteria, including Gardnerella vaginalis and others. The lactic acid drops, the pH rises, and the environment shifts to what researchers call dysbiosis.2PubMed. The role of lactic acid production by probiotic Lactobacillus species in vaginal health
Because BV involves a whole community of bacteria rather than one invading germ, it has resisted easy classification. Some data clearly link BV to sexual behavior, while other data suggest it can arise from purely internal shifts. A widely cited review summed this up well: despite findings linking sexual behavior and BV, some evidence indicates BV is not sexually transmitted in the traditional sense, while other evidence suggests it is an exogenous infection.3PubMed. Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma That ambiguity has persisted for years, though recent research has started tipping the scales toward a sexual-transmission model, at least in many cases.
Evidence That BV Bacteria Pass Between Male and Female Partners
One of the strongest pieces of evidence for sexual transmission comes from studies that looked directly at the bacteria living on men. Researchers sequenced the microbial communities on the penile skin, in the male urethra, and in the vaginas of monogamous heterosexual couples. When a woman had BV, her male partner’s penile and urethral bacteria looked remarkably similar to her own vaginal microbiome, more similar than to the vaginal bacteria of other women with BV. Specific BV-associated species were shared between partners. This wasn’t the case for couples where the woman had a normal vaginal microbiome.4PubMed Central. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis
A large study from Uganda reinforced this. Researchers identified distinct community types on the penis, ranging from low-density to high-density bacterial populations. Men whose penile bacteria fell into the higher-density community types, which carried more BV-associated organisms like Mobiluncus and Dialister, were significantly more likely to have a female partner with BV. The researchers concluded that the data support the exchange of BV-associated bacteria through intercourse, which could help explain why BV so often comes back after treatment.5PubMed Central. Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
In plain terms: the men themselves don’t get “BV” because they don’t have the same vaginal environment. But they can harbor the bacteria on and inside the penis, and those bacteria appear to travel back and forth during sex. Think of it less like “catching a disease” and more like two ecosystems exchanging species across a shared border.
The Partner Treatment Trial That Changed the Conversation
If BV bacteria pass between partners during sex, then treating only the woman while leaving her male partner untreated could be setting her up for reinfection. A landmark randomized trial tested exactly this idea. Women with BV were assigned either to have their male partners treated with a combination of oral and topical antibiotics, or to receive standard care where only the woman was treated. The results were striking: BV recurred in about a third of women in the partner-treatment group compared to nearly two-thirds of women in the control group.6PubMed. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
That trial made headlines and was interpreted by many as proof that BV is sexually transmitted. But the picture got murkier when a systematic review pooled it with earlier trials that had used different male-treatment approaches. The pooled analysis found no overall significant reduction in BV recurrence from treating male partners. When the researchers excluded that one trial that had used combined oral and topical antibiotics for men, the remaining trials showed essentially no benefit at all.7PubMed. The efficacy of male partner treatment to prevent recurrence of bacterial Vaginosis: A systematic review with Meta-Analysis of randomized controlled trials The takeaway is that how you treat the male partner matters a great deal. Simply handing the man a single antibiotic prescription may not be enough to clear the complex bacterial communities involved. It’s a promising area of research, but not yet a settled treatment recommendation.
Transmission Between Female Partners
The evidence for BV transmission between women who have sex with women is, in some ways, even more consistent than the evidence for male-female transmission. A systematic review found that BV was associated with having more female sexual partners and with having a current female partner who also had BV. Studies have reported high concordance of BV between women in sexual partnerships, meaning both partners tend to either have it or not.8PubMed Central. Factors Associated with Bacterial Vaginosis among Women Who Have Sex with Women: A Systematic Review
This is actually one of the strongest arguments against the idea that BV is purely an internal imbalance. If BV were just about individual hormonal shifts or hygiene habits, there would be no reason for partners to develop it in sync. The concordance between female sexual partners strongly supports direct transmission of the relevant bacteria.
Non-Sexual Factors That Shift the Balance
Sexual transmission doesn’t explain every case of BV. Several non-sexual factors influence whether your vaginal microbiome stays stable or tips toward dysbiosis.
Douching is the most consistently identified non-sexual risk factor. A study that adjusted for both demographic and sexual behavior factors found that frequent douching was significantly associated with BV, while other feminine hygiene products like sprays, powders, and wipes showed no meaningful connection. Underwear type, menstrual-product choice, and bathing frequency also didn’t show strong links.9PubMed Central. Personal hygienic behaviors and bacterial vaginosis In a small pilot study, women who stopped douching after their menstrual period saw their BV risk drop substantially compared to when they were douching regularly.10PubMed Central. The Effect of Vaginal Douching Cessation on Bacterial Vaginosis: A Pilot Study
Contraceptive choice also plays a role. Copper IUDs have been linked to increasing BV prevalence over time. One study tracked women after contraceptive initiation and found that BV prevalence among copper IUD users rose from about a quarter at baseline to roughly half by six months, with increasing concentrations of G. vaginalis and A. vaginae on the device.11PubMed Central. Impact of contraceptive initiation on vaginal microbiota By contrast, hormonal contraceptives generally appeared to maintain a more stable vaginal microbiome.12Frontiers in Microbiomes. The impact of contraceptives on the vaginal microbiome in the non-pregnant state A separate study found BV incidence was higher among IUD users at about 37% over six months, compared to roughly 19% in women using hormonal methods.13PubMed Central. Risk of Bacterial Vaginosis in Users of the Intrauterine Device: A Longitudinal Study This doesn’t mean copper IUDs are bad choices, but it’s worth knowing about if you’re prone to BV.
Ethnicity also influences vaginal microbiome composition in ways researchers are still working to understand. A population-based study in Amsterdam found that women of sub-Saharan African descent were significantly more likely to have vaginal microbiomes dominated by G. vaginalis, even after controlling for sexual behavior, hygiene practices, and hormonal contraceptive use.14PubMed Central. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands The reasons likely involve a combination of genetic, immune, and environmental factors that no single study has fully untangled.
Why BV Keeps Coming Back
Recurrence is BV’s most frustrating feature. Standard antibiotic treatment cures about four out of five women within 30 days, but as many as half experience a recurrence within a year.15PubMed Central. Understanding and Preventing Recurring Bacterial Vaginosis: Important Considerations for Clinicians 16PubMed. Characterization and Treatment of Recurrent Bacterial Vaginosis The reasons likely involve multiple overlapping mechanisms.
One major culprit is biofilm. The bacteria involved in BV don’t just float around freely; they form a tough, structured community attached to the vaginal lining. This polymicrobial biofilm protects the organisms inside it from antibiotics, which is why medication can kill the free-floating bacteria and clear symptoms temporarily while the biofilm persists underneath, ready to reseed the infection once antibiotics stop.17PubMed Central. Fighting polymicrobial biofilms in bacterial vaginosis It’s a bit like pulling weeds from the top while leaving the roots intact.
Reinfection from a sexual partner is another likely contributor, as described above. And there are specific virulence factors that help BV bacteria dig in. Gardnerella vaginalis produces enzymes called sialidases that strip sugar molecules off the protective mucus lining of the vagina, making it easier for BV bacteria to attach and for other pathogens to colonize.18PubMed Central. The role of sialidases in the pathogenesis of bacterial vaginosis and their use as a promising pharmacological target in bacterial vaginosis These enzymes essentially dismantle the vagina’s built-in defense layer.
Probiotics and the Push to Rebuild the Microbiome
Because antibiotics kill the bad bacteria without necessarily restoring the good ones, there’s growing interest in using Lactobacillus probiotics to give the vaginal ecosystem a jump-start after treatment. A randomized trial tested Lactin-V, a vaginal probiotic containing Lactobacillus crispatus, given after standard metronidazole treatment. By 12 weeks, BV had recurred in about 30% of women using the probiotic compared to 45% of women on placebo.19PubMed Central. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis A subsequent analysis found that the probiotic worked best in women who had already achieved a clinical cure from antibiotics before starting Lactin-V. Women who hadn’t responded well to the initial antibiotic course didn’t benefit from the probiotic either.20PubMed Central. Response to antibiotic treatment of bacterial vaginosis predicts the effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the prevention of recurrent disease
A separate trial in Chinese women compared intravaginal probiotic capsules to metronidazole and found comparable initial cure rates but significantly lower recurrence rates in the months following treatment.21Scientific Reports. Probiotics reduce the recurrence of asymptomatic bacterial vaginosis in Chinese women The logic behind all of these approaches is the same: antibiotics clear the field, and probiotics try to repopulate it with Lactobacillus before the BV community can rebuild. It’s a promising strategy but still evolving. Most vaginal probiotics currently sold over the counter haven’t been through rigorous clinical trials, so the gap between commercial claims and clinical evidence remains wide.
BV and the Risk of Other Infections
One reason clinicians take BV seriously beyond its symptoms is its connection to other sexually transmitted infections. A synthesis of the literature found that women with BV had roughly a 1.8- to 1.9-fold increased risk of acquiring gonorrhea or chlamydia.22PubMed Central. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections A longitudinal study confirmed a bidirectional relationship: BV appeared to precede acquisition of gonorrhea and chlamydia, and those infections in turn made BV more likely afterward.23PubMed. Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links
The mechanism makes sense when you think about what BV does to the vaginal environment. The acidic, Lactobacillus-rich conditions of a healthy vagina act as a barrier against incoming pathogens. When that barrier breaks down, the vagina becomes more hospitable to viruses and bacteria that would otherwise struggle to establish an infection. This is why BV has also been associated with increased susceptibility to HIV and HSV-2.
BV During Pregnancy
BV during pregnancy carries specific risks worth knowing about. A meta-analysis found that women with BV had roughly 1.4 to 1.8 times the odds of preterm birth compared to women without it.24PubMed. Effect of bacterial vaginosis on preterm birth: a meta-analysis An earlier large study found that the risk was highest when BV was accompanied by specific bacteria like Bacteroides and Mycoplasma hominis, which roughly doubled the odds of delivering a premature, low-birth-weight baby.25PubMed. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant Whether screening and treating asymptomatic BV in pregnant women actually prevents preterm birth remains debated in clinical guidelines, but the association itself is well established.
The Emotional Weight of Recurrent BV
The physical symptoms of BV, particularly the odor and discharge, are only part of the burden. Qualitative research has found that many women experience deep embarrassment, shame, and frustration that erode their self-esteem and confidence, leaving them feeling unattractive and insecure. Some women attributed this shame partly to broader societal stigma around female sexuality and STIs, which made them reluctant to seek help or discuss it with partners.26PubMed Central. The Burden of Bacterial Vaginosis: Women’s Experience of the Physical, Emotional, Sexual and Social Impact of Living with Recurrent Bacterial Vaginosis A scoping review confirmed that BV commonly affects sexual intimacy and relationships, with some women reporting avoidance behavior in social settings.27PubMed Central. Scoping review of the association between bacterial vaginosis and emotional, sexual and social health
The confusion around whether BV is “contagious” or an STI adds to this burden. Women sometimes feel caught between two narratives: one says it’s just an imbalance and nothing to worry about, while the other implies sexual transmission and possible blame. Neither narrative fully captures what’s happening, and the gap between them leaves a lot of women feeling unsupported. If you’re dealing with recurrent BV, understanding that it involves a genuinely complicated microbial ecology, not poor hygiene or promiscuity, can help reframe the experience.
Diagnosing BV Isn’t Always Straightforward
BV is typically diagnosed using either clinical criteria (checking for characteristic discharge, elevated pH, a fishy amine odor, and the presence of clue cells under a microscope) or by laboratory scoring of a vaginal smear. The laboratory approach, called Nugent scoring, is considered the gold standard, but it requires a microscope and trained personnel. The clinical approach is faster but less sensitive. One comparison found its sensitivity at only about 50% against the lab method, meaning half of true BV cases could be missed.28PubMed Central. Comparative study of Amsel’s criteria and Nugent scoring for diagnosis of bacterial vaginosis in a tertiary care hospital, Nepal Another study in HIV-infected women found that the clinical criteria were “poorly predictive” of BV as defined by the lab scoring method.29PubMed Central. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women Many cases of BV are also completely asymptomatic. One study found that only about a quarter of women with laboratory-confirmed BV reported vaginal symptoms at the time.30PubMed Central. Risk of Bacterial Vaginosis in Users of the Intrauterine Device: A Longitudinal Study So if you’ve been told conflicting things about whether you have BV at different appointments, or if you’ve had BV without realizing it, you’re far from alone.
What This Means Practically
The weight of recent evidence supports the idea that BV-associated bacteria travel between sexual partners, especially during unprotected sex. But BV also has non-sexual risk factors, can occur in women who are not sexually active, and involves a microbial shift that is fundamentally different from catching a single-pathogen STI. A reasonable way to think about it: sex is a major route through which the relevant bacteria are exchanged, but whether those bacteria actually displace your Lactobacillus and trigger BV depends on a constellation of other factors including your baseline microbiome, contraceptive method, hygiene habits, and probably genetics.
If you’re in a sexual partnership and dealing with recurrent BV, having a conversation with your clinician about concurrent partner treatment is worth considering, though the evidence is still developing. Avoiding douching is one of the clearest modifiable risk factors. And if you’re using a copper IUD and experiencing repeated BV episodes, it may be worth discussing alternative contraception with your provider. None of these measures guarantee prevention, because the microbial ecology at play is genuinely complex. But understanding what’s known, and what isn’t, puts you in a better position to manage it.